上客户端，和病友交流
点击下载
返回
宫颈癌

Robert Morris M.D.

妇科
Karmanos cancer center

擅长疾病

临床新药咨询

通过咨询找到适合自己的药物

专家咨询

专业、及时的一对一咨询

如果您的问题未能解决，您还可以选择：

医学顾问

极速咨询

2万名名医
为您匹配
1对1

找专家

肿瘤专科专家
对症找医专科专治

专家介绍

2015-06-19 14:322169
 ·         Gender

·         Male

·         Multidisciplinary Team(s)

·         Gynecologic Oncology 

·         Department/Research Program(s)

·         MDT Leader 
Gynecologic Oncology 

·         Cancer Type(s)

·         Cervical cancer 
Ovarian cancer 
Uterine cancer 

·         Contact Info

·         Email:
rmorris@med.wayne.edu

·        Education

·         Fellowship
University of Texas MD Anderson Cancer Center, Department of Gynecology
1996
Medical School
University of Minnesota
1984
Residency
Department of Obstetrics and Gynecology, Wayne State University School of Medicine
1994
Graduate Training
Doctoral studies at the University of Michigan, Ann Arbor, Michigan
1991
Graduate Training
Wayne State University School of Medicine, Cancer Biology Doctorate Program
1992

·         Professional Memberships/Associations

·         American College of Obstetricians and Gynecologists 
American College of Ob/Gyn 
American Medical Association 
American Society of Clinical Oncologists 
Central Association of Obstetricians and Gynecologists 
Society of Gynecologic Oncology 

·         Board Certifications

·         American Board of Obstetrics and Gynecology

·         Clinical Interests

·         Gynecologic Oncology 

·         Research Interests

·         Gynecologic Oncology 

·         Awards

·         1994 TeshimaExcellence in Gynecology
1992 Felix Rutledge Fellowship
1994 Holden Research Fellowship Grant
1991 NIH Human Genetic Training Grant
Voted one of Best Doctors Inc. 2011-2012 Best Doctors of the Year

·         Publications

·         Ovarian malignant mixed mullerian tumor with primitive neuroectodermal differentiation: Case report with review of the literature. Pathol Res Pract. 2011 Mar 15;207(3):202-6. Epub 2010 Oct 14. Authors: Nasser H, Morris RT, Fathallah L.
expression of GLUT-1 in epithelial ovarian carcinoma: Correlation with tumor cell proliferation, angiogenesis, survival and ability to predict optimal cytoreduction. Gynecol Oncol. 2011 Apr;121(1):181-6. Epub 2010 Dec 16. Authors: Semaan A, Munkarah AR, Arabi H, Bandyopadhyay S, Seward S, Kumar S, Qazi A, Hussein Y, Morris RT, Ali-Fehmi R.
The impact of race on survival in uterine serous carcinoma a hospital-based study. Gynecol Oncol. 2011 Jun 1;121(3):577-80. Epub 2011 Mar 4. Authors: Al-Wahab Z, Ali-Fehmi R, Cote ML, Elshaikh MA, Ibrahim DR, Semaan A, Schultz D, Morris RT, Munkarah AR.
Disparities in treatment and survival between African American and White women with vaginal cancer. Gynecol Oncol. 2011 Jul;122(1):38-41. Epub 2011 Apr 15. Authors: Mahdi H, Kumar S, Hanna RK, Munkarah AR, Lockhart D, Morris RT, Tamimi H, Swensen RE, Doherty M.
Stage IIA1 Versus Stage IIA2 Cervical Cancer: Does the New Staging Criteria Predict Survival? Int J Gynecol Cancer. 2011 May;21(4):711-6. Authors: Garg G, Shah JP, Toy EP, Christensen C, Deppe G, Asaad R, Morris RT.

 

1. 添加医学顾问微信，扫描☟二维码

2. 备注【癌种】进病友群

扫描预约专家咨询

专家科普

同类全球会诊
合作伙伴：